BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38223878)

  • 1. A rare neuroendocrine tumor of the lung.
    Karnan A
    Pan Afr Med J; 2023; 46():54. PubMed ID: 38223878
    [No Abstract]   [Full Text] [Related]  

  • 2. Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.
    Shimizu K; Goto Y; Kawabata-Iwakawa R; Ohtaki Y; Nakazawa S; Yokobori T; Obayashi K; Kawatani N; Yajima T; Kaira K; Mogi A; Hirato J; Nishiyama M; Shirabe K
    Ann Thorac Surg; 2019 Jul; 108(1):235-243. PubMed ID: 30910656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of immunohistochemical identification of neuroendocrine differentiation in non small cell lung carcinoma.
    Słodkowska J
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():23-7. PubMed ID: 9337520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Biopsy and Cytology of Pulmonary Neuroendocrine Neoplasms: Brief Overview of Classification, Immunohistochemistry, Molecular Profiles, and World Health Organization Updates.
    Sung S; Heymann JJ; Politis MG; Baine MK; Rekhtman N; Saqi A
    Adv Anat Pathol; 2022 Nov; 29(6):329-336. PubMed ID: 36053019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
    Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
    Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-cell neuroendocrine carcinoma of the lung: an aggressive neuroendocrine lung cancer.
    Fernandez FG; Battafarano RJ
    Semin Thorac Cardiovasc Surg; 2006; 18(3):206-10. PubMed ID: 17185180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
    Brcic L; Kuchler C; Eidenhammer S; Pabst D; Quehenberger F; Gazdar AF; Popper H
    Diagn Pathol; 2019 May; 14(1):47. PubMed ID: 31109352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Neuroendocrine Tumors.
    Borczuk AC
    Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic and molecular classification of lung neuroendocrine neoplasms.
    Metovic J; Barella M; Bianchi F; Hofman P; Hofman V; Remmelink M; Kern I; Carvalho L; Pattini L; Sonzogni A; Veronesi G; Harari S; Forest F; Papotti M; Pelosi G
    Virchows Arch; 2021 Jan; 478(1):5-19. PubMed ID: 33474631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
    Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
    APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung tumours with neuroendocrine differentiation.
    Travis WD
    Eur J Cancer; 2009 Sep; 45 Suppl 1():251-66. PubMed ID: 19775623
    [No Abstract]   [Full Text] [Related]  

  • 13. [Symptoms and diagnostics of lung neuroendocrine tumors].
    Tamási L; Müller V
    Orv Hetil; 2011 Mar; 152(10):366-70. PubMed ID: 21354952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
    Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
    Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
    Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
    Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
    Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
    Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.
    Dam G; Grønbæk H; Sundlöv A; Botling J; Sundin A; Petersen RH; Welin S; Evensen ET; Sorbye H; Tabaksblat E; Arveschoug AK; Mortensen J; Kjaer A; Knigge U; Tiensuu Janson E; Langer SW
    Acta Oncol; 2023 May; 62(5):431-437. PubMed ID: 37194281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall.
    Pezzuto F; Fortarezza F; Mammana M; Pasello G; Pelosi G; Rea F; Calabrese F
    Histopathology; 2020 Sep; 77(3):508-510. PubMed ID: 32502287
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification and Pathology of Lung Cancer.
    Zheng M
    Surg Oncol Clin N Am; 2016 Jul; 25(3):447-68. PubMed ID: 27261908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine tumors of the lung.
    Marchevsky AM
    Pathology (Phila); 1996; 4(1):103-23. PubMed ID: 8953616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.